Live
- Celebrating World Veterinary Day 2024: Safeguarding Your Pet’s Vision with Expert Tips
- NSG joins CBI in searching residence of Sheikh Shahjahan’s relative
- Maharashtra: Peeved state unit Congress Working President quits 2024 LS polls campaign
- Archery World Cup: Deepika storms into individual semis; Compound Mixed Team in final
- Adopt zero-tolerance approach towards terrorism, India tells SCO member states
- Free haircut, 'mehendi' for women on offer as Maharashtra votes in Phase 2
- BJP president JP Nadda to visit Odisha on April 28
- Participation of women in workforce is a constitutional entitlement: SC
- Sabita, Secretary of the District Legal Services Authority, made a surprise visit to the sub-jail
- Superstars Yash, Rakshit Shetty cast their votes, underline importance of polling
Kerala Develops An Effective Rt-PCR Kit To Identify Wide Variety Of Mutant Covid Strains
Kerala Develops An Effective Rt-PCR Kit To Identify Wide Variety Of Mutant Covid Strains
An RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit established by a medical institute in Kerala is said to have a higher detection rate.
An RT-PCR (Reverse Transcription Polymerase Chain Reaction) kit established by a medical institute in Kerala is said to have a higher detection rate. The multiplex RT-PCR kit, developed by the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), has 97.3 percent sensitivity and 100% specificity in COVID-19 detection, reported LiveMint .
The entire process takes about 45 minutes, not including the time it takes to isolate RNA from the nasopharyngeal swab samples.
In contrast to regular kits which are in use from the earlier times, which take about five to six hours to complete, the institute's latest kit is significantly faster. SCTIMST has signed an agreement with Huwel Life Sciences in Hyderabad to make it available to the general public.
The Indian Council of Medical Research, the country's apex health body controlling the coronavirus situation, has approved the latest technology, which is less likely to show any false positive cases and has a minimal 2.7 percent chance of predicting false negative cases.
According to the report the kit targets two genes of the SARS-CoV-2 and human RNAse P, which aids in the detection of a variety of mutant strains. It functions by amplifying all three genes in a single reaction, which is known as multiplex Taqman chemistry.
